- Home
- REPL vs NPKI Comparison
REPL vs NPKI Comparison
Compare REPL & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- NPKI
- Stock Information
- Founded
- REPL 2015
- NPKI 1932
- Country
- REPL United States
- NPKI United States
- Employees
- REPL N/A
- NPKI N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- NPKI Metal Fabrications
- Sector
- REPL Health Care
- NPKI Industrials
- Exchange
- REPL Nasdaq
- NPKI Nasdaq
- Market Cap
- REPL 757.8M
- NPKI 722.7M
- IPO Year
- REPL 2018
- NPKI N/A
- Fundamental
- Price
- REPL $9.21
- NPKI $8.65
- Analyst Decision
- REPL Strong Buy
- NPKI Strong Buy
- Analyst Count
- REPL 7
- NPKI 1
- Target Price
- REPL $20.83
- NPKI $12.00
- AVG Volume (30 Days)
- REPL 1.1M
- NPKI 923.0K
- Earning Date
- REPL 08-07-2025
- NPKI 08-04-2025
- Dividend Yield
- REPL N/A
- NPKI N/A
- EPS Growth
- REPL N/A
- NPKI N/A
- EPS
- REPL N/A
- NPKI N/A
- Revenue
- REPL N/A
- NPKI $233,299,000.00
- Revenue This Year
- REPL N/A
- NPKI $15.28
- Revenue Next Year
- REPL N/A
- NPKI $9.62
- P/E Ratio
- REPL N/A
- NPKI N/A
- Revenue Growth
- REPL N/A
- NPKI 312.30
- 52 Week Low
- REPL $6.44
- NPKI $4.76
- 52 Week High
- REPL $17.00
- NPKI $8.88
- Technical
- Relative Strength Index (RSI)
- REPL 53.47
- NPKI N/A
- Support Level
- REPL $9.15
- NPKI N/A
- Resistance Level
- REPL $9.64
- NPKI N/A
- Average True Range (ATR)
- REPL 0.50
- NPKI 0.00
- MACD
- REPL -0.06
- NPKI 0.00
- Stochastic Oscillator
- REPL 50.57
- NPKI 0.00
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.